House Rules for Debating Fentanyl Scheduling Bill (H.R. 27)
February 4, 2025
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
Where This Stands
Current status: passed_chamber.
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →The Frame
This resolution determines the specific legislative path for H.R. 27, dictating how much time lawmakers have to debate the bill and which amendments can be considered before a final vote on federal drug policy.
Potentially affected actors named in the source documents. Mention is not a position.
Committee on Energy and Commerce
The chair and ranking member are tasked with controlling the one hour of debate on the bill.
Members of the House of Representatives
Members are bound by the procedural constraints, including time limits and amendment restrictions, set by this resolution.
Current stage: passed_chamber.
Next step not available in the current record.
Summary
Key Facts
- The resolution authorizes the House to consider H.R. 27, a bill to amend the Controlled Substances Act regarding fentanyl-related substances.
- All points of order against the consideration of H.R. 27 are waived.
- The amendment printed in part A of the Rules Committee report is considered automatically adopted upon the resolution's passage.
- The bill is considered as read.
- All points of order against provisions in the amended bill are waived.
- Debate is limited to one hour, equally divided between the chair and ranking minority member of the Committee on Energy and Commerce.
- An additional amendment printed in part B of the report is permitted if offered by the designated member, with separate debate time.
- The resolution allows for one motion to recommit the bill.
Why It Matters
This resolution determines the specific legislative path for H.R. 27, dictating how much time lawmakers have to debate the bill and which amendments can be considered before a final vote on federal drug policy.
Frequently Asked Questions
What does this resolution actually do?
Will there be a public debate on the fentanyl bill?
News Coverage
Voting Record
Total
423
Yes
215
No
208
Present
0
Not Voting
0
Abstain
0
How they voted (423)
Jeff Crank
R · yes
Mike Kelly
R · yes
Yassamin Ansari
D · no
Eugene Vindman
D · no
Nancy Pelosi
D · no
Erin Houchin
R · yes
Mark Harris
R · yes
Valerie Foushee
D · no
Lisa McClain
R · yes
Judy Chu
D · no
Patrick Ryan
D · no
John Mannion
D · no
Mariannette Miller-Meeks
R · yes
Thomas Suozzi
D · no
Tony Gonzales
R · yes
John James
R · yes
Josh Harder
D · no
Zoe Lofgren
D · no
Pete Sessions
R · yes
Shomari Figures
D · no
Mike Carey
R · yes
Brandon Gill
R · yes
Lizzie Fletcher
D · no
Andrew Garbarino
R · yes
+ 399 more
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Expedited Legislative Process
The resolution uses multiple procedural tools—waiving points of order and pre-adopting an amendment—to accelerate the passage of H.R. 27.
Connected Entities
Sources
www.congress.gov
Analysis Score
0–100- Significance65How much this matters to a regular citizen
- Controversy40Intensity of disagreement among stakeholders
- Entertainment10Compellingness for a non-policy-wonk reader
- Buzz30Current news / social attention level
Publisher tools